Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P et al (2017) Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015. Circulation 136:1908–1919

Article  PubMed  Google Scholar 

Gale CP, Allan V, Cattle BA, Hall AS, West RM, Timmis A et al (2014) Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 100:582–589

Article  CAS  PubMed  Google Scholar 

Jernberg T, Johanson P, Held C, Svennblad B, Lindbäck J, Wallentin L (2011) Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 305:1677–1684

Article  CAS  PubMed  Google Scholar 

Bønaa KH, Halle KK, Govatsmark RES, Berge VB, Kiel IA, Sulo G, et al. Incidence and case fatality of acute myocardial infarction in Norway 2013–2021. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2024;144.

Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362:2155–2165

Article  CAS  PubMed  Google Scholar 

Chan MY, Sun JL, Newby LK, Shaw LK, Lin M, Peterson ED et al (2009) Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 119:3110–3117

Article  PubMed  Google Scholar 

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2024) 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149:e347–e913

Article  PubMed  PubMed Central  Google Scholar 

Thomas CD, Johnson JA (2020) Pharmacogenetic factors affecting β-blocker metabolism and response. Expert Opin Drug Metab Toxicol 16:953–964

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 127:529–555

Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64:e139–e228

Article  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44:3720–3826

Article  CAS  PubMed  Google Scholar 

Joo SJ, Kim SY, Choi JH, Park HK, Beom JW, Lee JG et al (2021) Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother 7:475–482

Article  PubMed  Google Scholar 

Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD et al (2014) Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 127:939–953

Article  CAS  PubMed  Google Scholar 

Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J et al (2019) Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 5:12–20

Article  PubMed  Google Scholar 

Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L et al (2024) Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med 390:1372–1381

Article  CAS  PubMed  Google Scholar 

Lee MG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ et al (2009) Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J 39:243–250

Article  PubMed  PubMed Central  Google Scholar 

Rapsomaniki E, Shah A, Perel P, Denaxas S, George J, Nicholas O et al (2014) Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J 35:844–852

Article  CAS  PubMed  Google Scholar 

Nauta ST, Deckers JW, Akkerhuis KM, van Domburg RT (2012) Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008. Diabetes Care 35:2043–2047

Article  PubMed  PubMed Central  Google Scholar 

Baviera M, Genovese S, Colacioppo P, Cosentino N, Foresta A, Tettamanti M et al (2022) Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction. Cardiovasc Diabetol 21:223

Article  PubMed  PubMed Central  Google Scholar 

Kang DG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ et al (2009) Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci 24:800–806

Article  PubMed  PubMed Central  Google Scholar 

Rembek M, Goch A, Goch J (2010) The clinical course of acute ST-elevation myocardial infarction in patients with hypertension. Kardiol Pol 68:157–163

PubMed  Google Scholar 

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

Article  PubMed  Google Scholar 

Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

CAS  PubMed  Google Scholar 

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

Article  CAS  PubMed  Google Scholar 

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

Article  CAS  PubMed  Google Scholar 

Konishi M, Haraguchi G, Yoshikawa S, Kimura S, Inagaki H, Isobe M (2011) Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization. Circ J 75:1982–1991

Article  CAS  PubMed  Google Scholar 

Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K et al (2019) Admission heart rate is a determinant of effectiveness of beta-blockers in acute myocardial infarction patients. Circ J 83:1054–1063

Article  CAS  PubMed  Google Scholar 

McMurray J, Køber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J et al (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 45:525–530

Article  CAS  PubMed  Google Scholar 

Yang JH, Hahn JY, Song YB, Choi SH, Choi JH, Lee SH et al (2014) Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv 7:592–601

Article  PubMed  Google Scholar 

Coiro S, Girerd N, Rossignol P, Ferreira JP, Maggioni A, Pitt B et al (2017) Association of beta‐blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched‐cohort analysis from the High‐Risk myocardial infarction database initiative. Eur J Heart Fail 19:271–279

Article  CAS  PubMed  Google Scholar 

Ishak D, Aktaa S, Lindhagen L, Alfredsson J, Dondo TB, Held C et al (2023) Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes. Heart 109:1159–1165

Article  PubMed  Google Scholar 

Choo EH, Chang K, Ahn Y, Jeon DS, Lee JM, Kim DB et al (2014) Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. Heart 100:492–499

Article  CAS  PubMed  Google Scholar 

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M et al (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 53:2150–2158